Medikal Fizik Çalışmaları
|
|
- Hilary Sanders
- 5 years ago
- Views:
Transcription
1 Medikal Fizik Çalışmaları 9 Kasım Vildan ALPAN Amerikan Hastanesi MDACC Kanser Merkezi, İstanbul
2 Learning Objectives To get an overview of the main current research directions in radiation therapy physics Five abstracts selected based on (a) their high scores from reviewers (b) their relevance to this audience (c) variety in treatment sites To understand the clinical impact of physics research in radiation oncology
3 Major Themes Treatment Planning and Delivery (in SRS/SBRT) Incident Learning for Stereotactic Radiation Therapy from RO-ILS: Radiation Oncology Incident Learning System (liver SBRT) Imaging for Response Assessment / Outcome analysis and modeling Radiogenomic Analysis of a Peritumoral CT Image Feature and its Prognostic Value in Early Stage NSCLC Regional dose differences associated with radiation-induced acute severe dysphagia (for H&N tumors)
4 Incident Learning for Stereotactic Radiation Therapy from RO-ILS: Radiation Oncology Incident Learning System D. J. Hoopes 1, E. C. Ford 2, G. A. Ezzell 3, A. P. Dicker 4, B. S. Chera 5, and L. Potters 6 1 University of California, San Diego, La Jolla, CA, 2 University of Washington Medical Center, Seattle, WA, 3 Mayo Clinic Arizona, Phoenix, AZ, 4 Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA, 5 Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, 6 Department of Radiation Medicine, Northwell Health, Lake Success, NY
5 Study Design / Purpose/Objective(s) The mission of RO-ILS is to facilitate safer and higher quality care in radiation oncology by providing a mechanism for shared learning. It is a voluntary incident learning system sponsored by ASTRO and AAPM. More than 300 facilities participate and more than 3000 cases have been submitted. Incident Learning REPORT ANALYZE MAKE IMPROVMENTS This study: Examine the patterns of errors reported for Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) using RO-ILS Lung Example: Conventional (2Gy x 30) vs SBRT (18Gy x 3), i.e. potentially half the targeting margin for error in a tenth of the total delivery sessions SRS/SBRT incidents were compared to non-stereotactic incidents.
6 Results Feb 2014 to Dec 2016: 2681 total incidents submitted 217 (8%) incidents were SRS/SBRT (no distinction) 40% SRS/SBRT RO-ILS Incidents Severity Scores, n=217 38% 35% 30% 25% 20% 15% 10% 5% 18% 24% 16% 4% Common event types: incorrect shift/alignment collisions/clearance incorrect site incorrect contours 0% Severity Scores 1 (Low) (High)
7 Results Near-miss Therapeutic Radiation Incident Unsafe Condition Other Process Operational Improvement SRS/SBRT, n=217 40% 25% 24% 7% 4% Non-SRS/SRT, n= % 34% 28% P-value Radiation incident: Error that reached the patient, and may or may not have caused harm. Differences between stereotactic and non-stereotactic events were statistically significant. Not shown: One third of the stereotactic events involved multiple patients (potential systematic errors). Stereotactic incidents are more likely to be near misses and less likely to reach the patient than conventional incidents
8 Results Dose Deviation (n=217) No deviation 92% Organ at Risk (OAR) 1% <5% of target dose 6% 5-25% of target dose 1% % target dose None >100% of target dose <1% In 92% of reported incidents, the error cause no dose deviation!
9 Authors Conclusions Significant dose deviations are uncommon in RO-ILS despite the complexity and risk of SRS/SBRT SRS/SBRT incidents are less likely to reach the patient than conventional incidents (heightened quality assurance requirements?)
10 Comments PRO: Illustrates the value of the RO-ILS system (Manuscript Common error pathways seen in the RO- ILS data that demonstrate opportunities for improving treatment safety in press in PRO; Demonstrates common error pathways in radiation oncology (most importantly errors defining targets, errors in manual processes, error in chart checks): This analysis of RO-ILS event data underscores the truism that verifying inputs to a process is more effective than testing outputs, especially when the output testing (e.g. plan checking by physics) is unlikely to discover the faulty input (e.g. target definition). CON: Voluntary reporting may cause bias Unclear how this knowledge can be used to improve treatments other than increase awareness
11 Radiogenomic Analysis of a Peritumoral CT Image Feature and Its Prognostic Value in Early Stage NSCLC J. Lee 1, Y. Cui 2, M. F. Gensheimer 3, B. W. Loo Jr 3, M. Diehn 3, and R. Li 4 1 Stanford University, Palo Alto, CA, 2 Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan, 3 Stanford Cancer Institute, Stanford, CA, 4 Stanford University, Stanford, CA
12 Study Design / Purpose/Objective(s) Early-Stage NSCLC Increased prevalence with screening. Excellent local control after surgery or SABR. Distant metastasis remains a major problem (20-30%). Biomarkers are need to inform adjuvant therapy. Typical Prognostic Imaging Biomarkers Tumor size: TNM staging Most radiomic studies focus on gross tumor only Tumor texture and morphology: less established Few look beyond the tumor and invaded surrounding tissue Study aims: Identify patients with high risk of relapse. Determine the prognostic value of pleural contact. Identify the molecular basis of pleural contact.
13 Study Design / Methods Pleural invasion has been shown to correlate with poor prognosis in resected NSCLC Simple attachment to pleura does not necessarily imply invasion. Quantitative PCI: quantify relation of tumor and surrounding pleura based on CT Retrospectively analyzed 7 NSCLC cohorts (n=1069). PCI = pleural contact length Dmax PCI: 0.5 2cm PCI: 1 Stage I only.
14 Study Design / Methods Cohorts 1-2: Discovery cohort (n=117; pre-treatment CT and outcomes available) and external validation cohort (n=88). Cohort 3: Publicly available (n=89) patients with both imaging and gene expression data to identify the molecular basis of PCI and build a gene expression-based surrogate (radiogenomic classifier). Cohorts 4-7: Further tested prognostic relevance using four datasets (n=775) with publically available gene expression data and linked survival information.
15 Overall survival Overall survival Results Cohorts 1-2: PCI was prognostic, while pleural attachment was not. A cutoff of 0.8, PCI stratified patients (when using both internal and external cohorts) PCI was associated with survival beyond age, gender, tumor size, histology. Correlation did hold for small and large tumor volumes Stanford cohort European cohort
16 Results Cohort 3: 89 patients with gene expression (1919 genes correlated with PCI) and CT image data Extracellular matrix (ECM) remodeling was enriched among genes correlated with PCI (false discovery rate (FDR)=0.005) Remodeling of the ECM plays an important role in cancer invasion/metastasis. Cohorts 4-7: 775 patients with gene expression and survival in GEO (gene expression omnibus). The genomic surrogate of PCI: stratified patients for overall survival in all 4 cohorts remained a strong, independent prognostic factor GSE30219
17 Results PCI significantly stratified patients for overall survival in both discovery (log-rank test P = ) and validation (log-rank test P = ) imaging cohorts. PCI stratified patients for distant metastasis in the discovery cohort (log-rank test P = ). PCI was significantly associated with genes related to extracellular matrix organization/disassembly and collagen catabolic process (Spearmen test P < 0.05). This suggests association between PCI and metastasis-prone tumor microenvironment. The radiogenomic classifier stratified patients for overall survival in each of four gene expression cohorts (log-rank test P range: < to 0.019) and remained an independent predictor when adjusting for age, gender, and tumor stage (Wald test P = ).
18 Authors Conclusions Pleural contact index (PCI) can serve as a noninvasive prognostic marker and might be used to guide risk-adapted therapy in early stage NSCLC. Tumors with higher PCI may be driven by ECM remodeling. Prospective studies are needed to confirm these findings. Radiogenomic strategy can be used to identify biological meaningful and clinical relevant imaging biomarkers in other cancer types.
19 Comments PRO: Biomarkers are needed that can reliably predict disease recurrence and more aggressive disease to guide the management of lung cancer considering the toxicities associated with chemotherapy. Association between imaging (PCI) and molecular (ECM) phenotypes. CON: Study shows correlative relations but not causative relations Retrospective study Many published prognostic markers simply correlate with tumor volume (study found moderate correlation between PCI and tumor volume in one cohort) Study has recently been published: Eur Radiol Aug 7
20 Regional dose differences associated with radiation-induced acute severe dysphagia S. Monti 1, G. Palma 2, V. D'Avino 2, M. Gerardi 3, D. Ciardo 3, D. Alterio 3, B. A. Jereczek-Fossa 3,4, M. Quarantelli 2, R. Pacelli 5, and L. Cella 2 1 IRCCS SDN, Napoli, Italy, 2 National Research Council, Institute of Biostructures and Bioimaging, Napoli, Italy, 3 Istituto Europeo di Oncologia, Milano, Italy, 4 Department of Oncology and Hematooncology, University of Milan, Milano, Italy, 5 Federico II University School of Medicine, Department of Advanced Biomedical Sciences, Napoli, Italy
21 Study Design / Purpose/Objective(s) To apply a voxel-based analysis (VBA) to explore correlation between radiation induced acute dysphagia (RIAD) and local dose release in patients treated for head and neck (H&N) tumors. Different dose distributions can have the same DVH! Alpha Bravo VBA permits to overcome the limitations of DVH-based or single organ analysis Definition and contouring of swallowing-related normal tissues can be time consuming and prone to operator variations
22 Study Design / Methods 42 Head & Neck (H&N) patients treated with definitive RT and no previous surgery: 23 3D CRT 19 IMRT Median total prescribed dose of 70 Gy (35 fractions of 2 Gy) 41 patients received concurrent (35/42) or induction (6/42) chemotherapy 9 patients developed a severe (CTCAE v4.0 grade 3) RIAD. None of the clinical variables showed a significant correlation with RIAD.
23 Study Design / Methods Planning CTs are registered to the common coordinate system (CCS) by an elastic image registration (EIR) tool. The obtained deformation fields are used to warp the dose maps into the CCS. A statistical mapping scheme (TFCE) is applied to extract the clusters of voxels (S 0.05 ) significantly associated with higher doses released in patients developing the radiation induced toxicity.
24 Results Dose distributions given to patients who (a) developed RIAD (b) did not developed RIAD The TFCE analysis showed that a significantly higher dose was delivered to RIAD patients in two voxel clusters (c) dose difference map (d) statistical significant dose difference located in the cricopharyngeus muscle and the cervical esophagus. (a) (c) (b) (d)
25 Results Dose differences between groups Overall S 0.05 volume = 5.1 cm 3 ; Mean dose in S 0.05 separates RIAD (median = 48 Gy) non-riad (median = 33 Gy) ROC-AUC = S 0.05
26 Authors Conclusions The work goes beyond the organ-based philosophy in the analysis of radiation induced toxicity in H&N H&N sites are challenging for registration process due to: High mobility of the structures Considerable inter-patient anatomical variability A correlation was found between RIAD and local dose differences in regions that are likely associated with the swallowing function
27 Comments PRO: Voxel based analysis does not require prior knowledge of anatomical regions Correlation between the dose delivered in a specific region of the swallowinginvolved organs and the RIAD onset can be exploited to construct an avoidance criterion in the planning optimization strategy. Data may allow further insight into spatial distribution of radiation sensitivity. CON: Patient variability (results apply to average patient) Small cohort Study has been published: Scientific Reports 7: 7220 (2017)
28 TEŞEKKÜRLER La Jolla/ San Diego
Novel techniques for normal tissue toxicity modelling. Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy
Novel techniques for normal tissue toxicity modelling Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy Disclosure: I have no conflict of interest An honorarium is
More information8/1/2017. Imaging and Molecular Biomarkers of Lung Cancer Prognosis. Disclosures. The Era of Precision Oncology
Imaging and Molecular Biomarkers of Lung Cancer Prognosis Ruijiang Li, PhD Assistant Professor of Radiation Oncology 08/01/2017 Stanford University Department of Radiation Oncology School of Medicine Disclosures
More informationMedikal Fizik Çalışmaları
Medikal Fizik Çalışmaları Zeynep Özen Acıbadem Altunizade Hastanesi Major Themes Treatment Planning and Delivery (in SRS/SBRT) Improving Quality and Consistency in Clinical Trials via Knowledge- Based
More informationPatient Safety in the Age of Big Data
CIRMS 2018 Patient Safety in the Age of Big Data Machine Learning, Measurements, and Standards for Making Radiation Treatments Safer Christopher Berlind, PhD Co-founder and Chief Technology Officer, Oncora
More informationStereotactic ablative radiotherapy in early NSCLC and metastases
Stereotactic ablative radiotherapy in early NSCLC and metastases Scheduled: 0810-0830 hrs, 10 March 2012 Professor Suresh Senan Department of Radiation Oncology SABR in stage I NSCLC A major treatment
More informationLONG-TERM SURGICAL OUTCOMES OF 1018 PATIENTS WITH EARLY STAGE NSCLC IN ACOSOG Z0030 (ALLIANCE) TRIAL
LONG-TERM SURGICAL OUTCOMES OF 1018 PATIENTS WITH EARLY STAGE NSCLC IN ACOSOG Z0030 (ALLIANCE) TRIAL Stacey Su, MD; Walter J. Scott, MD; Mark S. Allen, MD; Gail E. Darling, MD; Paul A. Decker, MS; Robert
More informationMight Adaptive Radiotherapy in NSCLC be feasible in clinical practice?
Might Adaptive Radiotherapy in NSCLC be feasible in clinical practice? E.Molfese, P.Matteucci, A.Iurato, L.E.Trodella, A.Sicilia, B.Floreno, S.Ramella, L.Trodella Radioterapia Oncologica, Università Campus
More informationSBRT in Pancreas Cancer Role of The Radiosurgery Society
SBRT in Pancreas Cancer Role of The Radiosurgery Society Anand Mahadevan MD FRCS FRCR Chairman Division of Radiation Oncology Geisinger Health System, Danville, PA, USA. Past President and Chairman: The
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationReirradiazione. La radioterapia stereotassica ablativa: torace. Pierluigi Bonomo Firenze
Reirradiazione La radioterapia stereotassica ablativa: torace Pierluigi Bonomo Firenze Background Stage III NSCLC isolated locoregional recurrence in 25% of pts mostly unresectable; low RR with 2 nd line
More informationInsights into Thymic Epithelial Tumors: Radiation Therapy
Insights into Thymic Epithelial Tumors: Radiation Therapy Charles R. Thomas, MD Professor and Chairman, Department of Radiation Medicine Professor, Department of Medicine, Division of Hematology/Medical
More informationFlattening Filter Free beam
Dose rate effect in external radiotherapy: biology and clinic Marta Scorsetti, M.D. Radiotherapy and Radiosurgery Dep., Istituto Clinico Humanitas, Milan, Italy Brescia October 8th/9th, 2015 Flattening
More informationBeyond the DVH: Voxelbased Automated Planning and Quality Assurance
1 Beyond the DVH: Voxelbased Automated Planning and Quality Assurance Presented by Chris McIntosh Research Associate Department of Medical Imaging & Physics Princess Margaret Cancer Centre C. McIntosh
More information8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET
PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationThe Smart Way to Check Treatment Plans and Charts. Anne W. Greener, Ph.D., FACR American Association Of Medical Dosimetrists June 15, 2016
The Smart Way to Check Treatment Plans and Charts Anne W. Greener, Ph.D., FACR American Association Of Medical Dosimetrists June 15, 2016 Conflicts NONE Professional Affiliations AAPM Liaison to the AAMD
More informationThe TomoTherapy System as a Tool of Differentiation in Quality and Marketability
The TomoTherapy System as a Tool of Differentiation in Quality and Marketability John J. Kresl, MD, PhD, FACRO, FACR Medical Director Phoenix CyberKnife & Radiation Oncology Center Managing Partner Phoenix,
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationU.S. Army Medical Research and Materiel Command Fort Detrick, Maryland Distribution Unlimited
AWARD NUMBER: W81XWH-12-1-0236 TITLE: PRINCIPAL INVESTIGATOR: EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer Billy
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationAdvaMed Medtech Value Assessment Framework in Practice
AdvaMed Medtech Value Assessment Framework in Practice Application of the Medtech Value Assessment Framework to Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Value Framework Overview
More informationQUARTERLY REPORT PATIENT SAFETY WORK PRODUCT Q J A N UA RY 1, 2016 MA R C H 31, 2016
QUARTERLY REPORT PATIENT SAFETY WORK PRODUCT Q1 2016 J A N UA RY 1, 2016 MA R C H 31, 2016 CLARITY PSO, a Division of Clarity Group, Inc. 8725 West Higgins Road Suite 810 Chicago, IL 60631 T: 773.864.8280
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationClinical Protontherapy Head and Neck cancer
Clinical Protontherapy Head and Neck cancer Coen Rasch Department of Radiation Oncology Academic Medical Center Amsterdam No disclosures 1 Introduction Proton vsphotonin the literature Model basedindicationprotocol
More informationMarco Trovò CRO-Aviano
From pre-clinical research to clinical practice in radiation therapy: new predictive factors and biological markers to predict normal tissue toxicity after radiation therapy of the lung. Marco Trovò CRO-Aviano
More informationLinac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery
Linac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery FILIPPO ALONGI MD Radiation Oncology & Radiosurgery Istituto Clinico
More informationImproving the Diagnostic Specificity of CT for Early Detection of Lung Cancer: 4D CT-Based Pulmonary Nodule Elastometry. Menlo Park, CA
AWARD NUMBER: W81XWH-12-1-0287 TITLE: Improving the Diagnostic Specificity of CT for Early Detection of Lung Cancer: 4D CT-Based Pulmonary Nodule Elastometry PRINCIPAL INVESTIGATOR: Billy Loo Jr., MD PhD
More informationTIP SHEET: TARGETED RADIATION FOR CHILDHOOD CANCER AND PROGRESS IN LOWERING TREATMENT COSTS AMONG RESEARCH PRESENTATIONS BY JOHNS HOPKINS SCIENTISTS
Johns Hopkins Kimmel Cancer Center Office of Public Affairs Media Contacts: Vanessa Wasta, 410-614-2916, wasta@jhmi.edu Amy Mone, 410-614-2915, amone@jhmi.edu TIP SHEET: TARGETED RADIATION FOR CHILDHOOD
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationand Strength of Recommendations
ASTRO with ASCO Qualifying Statements in Bold Italics s patients with T1-2, N0 non-small cell lung cancer who are medically operable? 1A: Patients with stage I NSCLC should be evaluated by a thoracic surgeon,
More informationPancreatic Cancer and Radiation Therapy
Pancreatic Cancer and Radiation Therapy Why? Is there a role for local therapy with radiation in a disease with such a high rate of distant metastases? When? Resectable Disease Is there a role for post-op
More informationStereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors
Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors Anna Bruynzeel, Radiation Oncologist VU University Medical Center, Amsterdam, The Netherlands Current standard
More informationOutline. WBRT field. Brain Metastases. Whole Brain RT Prophylactic WBRT Stereotactic radiosurgery (SRS) 1 fraction Stereotactic frame
Radiation Therapy for Advanced NSC Lung Ca Alexander Gottschalk, M.D., Ph.D. Associate Professor Director of CyberKnife Radiosurgery Department of Radiation Oncology University of California San Francisco
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationAutomated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist
Automated Plan Quality Check with Scripting Rajesh Gutti, Ph.D. Clinical Medical Physicist Veera.Gutti@BSWHealth.org Outline Introduction - BSW Automation in Treatment planning Eclipse Scripting API Script
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationRadiation Therapy for Liver Malignancies
Outline Radiation Therapy for Liver Malignancies Albert J. Chang, M.D., Ph.D. Department of Radiation Oncology, UCSF March 23, 2014 Rationale for developing liver directed therapies Liver directed therapies
More information8/2/2018. Disclosure. Online MR-IG-ART Dosimetry and Dose Accumulation
Online MR-IG-ART Dosimetry and Dose Accumulation Deshan Yang, PhD, Associate Professor Department of Radiation Oncology, School of Medicine Washington University in Saint Louis 1 Disclosure Received research
More informationCON: Removal of the Breast Primary in Patients with Metastatic Breast Cancer
CON: Removal of the Breast Primary in Patients with Metastatic Breast Cancer Amelia B. Zelnak, M.D., M.Sc. Assistant Professor of Hematology and Medical Oncology Winship Cancer Institute Emory University
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationPatient-Specific QA & QA Process. Sasa Mutic, Ph.D. Washington University School of Medicine
Patient-Specific QA & QA Process Sasa Mutic, Ph.D. Washington University School of Medicine Outline of Presentation QA and QC in RT Safety vs. quality Patient specific QM program Learning Objectives Describe
More informationAn Update on Radiation Therapy for Prostate Cancer
An Update on Radiation Therapy for Prostate Cancer David C. Beyer, MD, FACR, FACRO, FASTRO Arizona Oncology Services Phoenix, Arizona Objectives Review significant new data Identify leading trends in PCa
More informationA Prospective Phase II Trial of Deintensified Chemoradiation Therapy for Low Risk HPV Associated Oropharyngeal Squamous Cell Carcinoma
A Prospective Phase II Trial of Deintensified Chemoradiation Therapy for Low Risk HPV Associated Oropharyngeal Squamous Cell Carcinoma B. S. Chera 1, R. J. Amdur 2, J. E. Tepper 3, B. Qaqish 4, R. Green
More informationThe 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics
More informationMRI Applications in Radiation Oncology:
MRI Applications in Radiation Oncology: Physician s Perspective Jeff Olsen, MD Department of Radiation Oncology Washington University, St. Louis, MO Disclosures Washington University has research and service
More informationClinical Study Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
Pulmonary Medicine Volume 2012, Article ID 369820, 5 pages doi:10.1155/2012/369820 Clinical Study Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
More information8/2/2017. Improving Dose Prescriptions for Safety, Reporting, and Clinical Guideline Consistency. Part III
Improving Dose Prescriptions for Safety, Reporting, and Clinical Guideline Consistency Part III I Das, J Moran, M Langer Keeping Guidelines On Track: The Effect On Clinical Practice of Neglecting Guidelines
More informationWhere are we with radiotherapy for biliary tract cancers?
Where are we with radiotherapy for biliary tract cancers? Professor Maria A. Hawkins Associate Professor in Clinical Oncology MRC Group Leader/Honorary Consultant Clinical Oncologist CRUK MRC Oxford Institute
More informationStereotactic Body Radiotherapy (SBRT) For HCC T A R E K S H O U M A N P R O F. R A D I A T I O N O N C O L O G Y N C I, C A I R O U N I V.
Stereotactic Body Radiotherapy (SBRT) For HCC T A R E K S H O U M A N P R O F. R A D I A T I O N O N C O L O G Y N C I, C A I R O U N I V. Hepatocellular carcinoma (HCC), is a major health problem worldwide.
More informationOverview of Clinical and Research Activities at Georgetown University Hospital
Overview of Clinical and Research Activities at Georgetown University Hospital Dalong Pang, Ph.D. Department of Radiation Medicine Georgetown University Hospital Clinical Operation Two Varian linear accelerators
More informationNational System for Incident Reporting in Radiation Therapy (NSIR-RT) Taxonomy
Canadian Partnership for Quality Radiotherapy (CPQR) National System for Incident Reporting in Radiation Therapy (NSIR-RT) National System for Incident Reporting in Radiation Therapy (NSIR-RT) Taxonomy
More informationTop Studies in Cancer Imaging and Radiation Therapy
Top Studies in Cancer Imaging and Radiation Therapy Moderated by Julia White, MD, Ohio State University Comprehensive Cancer Center, and Michael Cohen, MD, Emory University Hepatic Function Model Based
More informationMedical Events. Florida Department of Health Division of Emergency Preparedness and Community Support Bureau of Radiation Control
Medical Events Florida Department of Health Division of Emergency Preparedness and Community Support Bureau of Radiation Control April 6, 2018 Presented by: Clark Eldredge Authority for Regulation Each
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationThe RSS and ACRO Program for Distinction in Stereotactic Radiation Therapy
The RSS and ACRO Program for Distinction in Stereotactic Radiation Therapy Practical Medical Physics: Radiation Oncology Accreditation Programs AAPM Annual Meeting, Nashville, TN July 30, 7:30-9:30 Presented
More informationImaging e tecnologia: cosa c è dietro l angolo?
Reggio Emilia, 17 Aprile 2010 Imaging e tecnologia: cosa c è dietro l angolo? Claudio Fiorino Fisica Sanitaria Istituto Scientifico San Raffaele, Milano Premessa Imaging e RT.una lunga storia.. La RT attuale
More informationQuantitative Radiomics System Decoding the Tumor Phenotype. John Quackenbush and Hugo Aerts
Quantitative Radiomics System Decoding the Tumor Phenotype John Quackenbush and Hugo Aerts The Radiomics Hypothesis The tumor s structural phenotype reflects its molecular and clinical properties. This
More informationTreatment of oligometastases: Lung
Treatment of oligometastases: Lung Themadag Catharina ZH 30 March 2017 Max Dahele Radiation Oncologist Vumc, Amsterdam m.dahele@vumc.nl Do you all treat lung oligometastases? What is your definition of
More informationPalliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased
Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased analysis Roel Schlijper Fellow Radiation Oncology BC Cancer, Prince George Disclosures No conflicts
More informationUniversity of California, Los Angeles, Los Angeles, CA, 2 FROS Radiation Oncology and CyberKnife Center, Flushing, NY, 3
Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study A. U. Kishan 1, A. Katz 2, C. A. Mantz 3, F. I.
More informationTherapy of Non-Operable early stage NSCLC
SBRT Stage I NSCLC Therapy of Non-Operable early stage NSCLC Dr. Adnan Al-Hebshi MD, FRCR(UK), FRCP(C), ABR King Faisal Specialist Hospital & Research Centre This is our territory Early Stages NSCLC Surgical
More informationRTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman
RTOG Lung Cancer Committee 2012 Clinical Trial Update Wally Curran RTOG Group Chairman 1 RTOG Lung Committee: Active Trials Small Cell Lung Cancer Limited Stage (Intergroup Trial) Extensive Stage (RTOG
More informationMRI-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
MRI-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer Daniel Golden Postdoctoral Scholar (Radiology) Stanford University Daniel Rubin Laboratory NCI Cancer Imaging Fellowship Seminar
More informationOn the use of 4DCT derived composite CT images in treatment planning of SBRT for lung tumors
On the use of 4DCT derived composite CT images in treatment planning of SBRT for lung tumors Zhe (Jay) Chen, Ph.D. Department of Therapeutic Radiology Yale University School of Medicine and Yale-New Haven
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationTecniche Radioterapiche U. Ricardi
Tecniche Radioterapiche U. Ricardi UNIVERSITA DEGLI STUDI DI TORINO Should we always rely on stage? T4N0M0 Stage IIIB T2N3M0 Early stage NSCLC The treatment of choice for early-stage NSCLC is anatomic
More informationThe Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology
The Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology (specifically, lung cancer) 2/10/18 Jeffrey Kittel, MD Radiation Oncology, Aurora St. Luke s Medical Center Outline The history
More informationHypofractionated radiation therapy for glioblastoma
Hypofractionated radiation therapy for glioblastoma Luis Souhami, MD, FASTRO Professor McGill University Department of Oncology, Division of Radiation Oncology Montreal Canada McGill University Health
More informationPaolo Tini 1,3 M.D. :
Correlazione tra espressione di Epidermal Growth Factor Receptor (EGFR) e Patterns di recidiva/progressione di malattia dopo trattamento radio-chemioterapico in pazienti affetti da Glioblastoma (GB). Paolo
More informationDevelopment of an Expert Consensus Target Delineation Atlas for Thymic Cancers: Initial Quantitative Analysis of an Expert Survey.
Development of an Expert Consensus Target Delineation Atlas for Thymic Cancers: Initial Quantitative Analysis of an Expert Survey. Charles R. Thomas, Jr., MD, Jayashree Kalpathy-Cramer, PhD, Jehee Choi,
More informationInternational RT Clinical Trial Group Membership & Quality Control BY DR YING XIAO
International RT Clinical Trial Group Membership & Quality Control BY DR YING XIAO Disclosures The Department of Radiation Oncology at Hospital of University of Pennsylvania has a research agreement with
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More informationLung Cancer Radiotherapy
Lung Cancer Radiotherapy Indications, Outcomes, and Impact on Survivorship Care Malcolm Mattes, MD Assistant Professor WVU Department of Radiation Oncology When people think about radiation, they think
More informationThe Clinical Research E-News
Volume 2: ISSUE 6: March 24, 2010 The Clinical Research E-News SPECIAL ALERT: The annual JOG investigator Meeting will be held at 5pm on May 10, 2010 at the Loews Hotel. Now Open: AZ1071, A Phase II Study
More informationSBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session
Stereotactic Body Radiation Therapy Quality Assurance Educational Session J Perks PhD, UC Davis Medical Center, Sacramento CA SBRT fundamentals Extra-cranial treatments Single or small number (2-5) of
More informationClinical Implications Of Dose Summation And Adaptation
Clinical Implications Of Dose Summation And Adaptation Patrick Kupelian, M.D. Professor and Vice Chair University of California Los Angeles Department of Radiation Oncology pkupelian@mednet.ucla.edu August
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationNew Radiation Treatment Modalities in the Treatment of Lung Cancer
New Radiation Treatment Modalities in the Treatment of Lung Cancer David Perry, M.D. Chief, Radiation Oncology Medical Director, CyberKnife Radiosurgery Center Medstar Franklin Square Medical Center Definitions
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More informationApplying Tissue Phenomics to Colorectal Clinical Questions
Applying Tissue Phenomics to Colorectal Clinical Questions International Symposium for Tissue Phenomics San Francisco October 2014 Peter Caie Senior Research Fellow University of St Andrews Systems Pathology
More informationProstate Cancer Appraisal Addendum: Stereotactic Body Radiation Therapy (SBRT)
Prostate Cancer Appraisal Addendum: Stereotactic Body Radiation Therapy (SBRT) The Institute for Clinical and Economic Review (ICER) has published appraisals on multiple management options for clinically-localized,
More informationClinical Trial Credentialing:
IROC Mission Clinical Trial Credentialing: Provide integrated radiation oncology and diagnostic Where imaging to Start quality and control programs in support of the NCI s NCTN Network thereby Resources
More informationART for Cervical Cancer: Dosimetry and Technical Aspects
ART for Cervical Cancer: Dosimetry and Technical Aspects D.A. Jaffray, Ph.D. Radiation Therapy Physics Princess Margaret Cancer Centre/Techna/Ontario Cancer Institute Professor Departments of Radiation
More informationQA for Clinical Dosimetry with Emphasis on Clinical Trials
QA for Clinical Dosimetry with Emphasis on Clinical Trials Geoffrey S. Ibbott, Ph.D. and RPC Staff G. Ibbott, AAPM Summer School, June 24, 2009 1 QA Infrastructure for Clinical Trials Participating Institutions
More informationProtocolos de consenso: MTS Cerebrales Resumen ASTRO. Javier Aristu y Germán Valtueña Servicio Oncología Rad. Depart.
Protocolos de consenso: MTS Cerebrales Resumen ASTRO Javier Aristu y Germán Valtueña Servicio Oncología Rad. Depart. ASTRO 2013 Brain met SRS Abstracts 97. Comparative Effectiveness of SRS versus WBRT
More informationTITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer
AD Award Number: W81XWH-04-1-0769 TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer PRINCIPAL INVESTIGATOR: Richard K. Valicenti,
More informationCPT code semantics 8/18/2011. SBRT Planning Case Studies. Spectrum of applications of SBRT. itreat
Spectrum of applications of SBRT EDUCATIONAL COURSE Physics and Dosimetry of SBRT Part III: Planning Case Studies Brian D. Kavanagh, MD, MPH Department of Radiation Oncology University of Colorado School
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More informationTHE ROLE OF RADIATION THERAPY IN MANAGEMENT OF PANCREATIC ADENOCARCINOMA. TIMUR MITIN, MD, PhD
THE ROLE OF RADIATION THERAPY IN MANAGEMENT OF PANCREATIC ADENOCARCINOMA TIMUR MITIN, MD, PhD RESECTABLE DISEASE MANAGEMENT: RESECTABLE DISEASE Resection offers the only possibility of long term survival
More informationResearch and Reviews Journal of Medical and Clinical Oncology
Comparison and Prognostic Analysis of Elective Nodal Irradiation Using Definitive Radiotherapy versus Chemoradiotherapy for Treatment of Esophageal Cancer Keita M 1,2, Zhang Xueyuan 1, Deng Wenzhao 1,
More informationDoes the lung nodule look aggressive enough to warrant a more extensive operation?
Accepted Manuscript Does the lung nodule look aggressive enough to warrant a more extensive operation? Michael Kuan-Yew Hsin, MBChB, MA, FRCS(CTh), David Chi-Leung Lam, MD, PhD, FRCP (Edin, Glasg & Lond)
More informationIntroduction. The HER2 Testing Expert Panel has identified five Clinical Questions that form the core of this Focused Update.
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/ College of American Pathologists Clinical Practice Guideline Focused Update Wolff, et al. Introduction
More informationSBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING ADVANCES IN
DEPARTMENT OF RADIATION ONCOLOGY ADVANCES IN SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING OCTOBER 21, 2018 MARRIOTT
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationPotential conflicts-of-interest. Respiratory Gated and Four-Dimensional Tumor Tracking Radiotherapy. Educational objectives. Overview.
Respiratory Gated and Four-Dimensional Tumor Tracking Radiotherapy Potential conflicts-of-interest I am PI of a sponsored research agreement between Stanford University and Varian Medical Systems P Keall
More informationMehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey
Updated Oncology 2015: State of the Art News & Challenging Topics CURRENT STATUS OF STEREOTACTIC RADIOSURGERY IN BRAIN METASTASES Mehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey Bucharest,
More informationSurgery versus stereotactic body radiation therapy in medically operable NSCLC
Surgery versus stereotactic body radiation therapy in medically operable NSCLC David H Harpole Jr, MD Professor of Surgery Associate Professor in Pathology Vice Chief, Division of Surgical Services Duke
More informationSBRT in early stage NSCLC
SBRT in early stage NSCLC Optimal technique and tumor dose Frank Zimmermann Clinic of Radiotherapy and Radiation Oncology University Hospital Basel Petersgraben 4 CH 4031 Basel radioonkologiebasel.ch Techniques
More information